Details Basic Details Status Ongoing Last Updated Tuesday, October 10, 2023 Original Posting Date Tuesday, October 10, 2023 Health Outcome(s) COVID-19 hospitalization, Severe COVID-19 Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Analytic Code Link(s) (1) COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis